Lumiliximab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lumiliximab, covering 2015-10-02 to 2015-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 2]